MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Capital Expenditures (2017 - 2025)

MeiraGTx Holdings' (MGTX) quarterly Capital Expenditures came in at $272000.0 in Q4 2025, down 77.67% YoY from $1.2 million in Q4 2024, and down 55.41% on a QoQ basis from $610000.0 in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Capital Expenditures (2017 - 2025) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Capital Expenditures data on file, last reported at $272000.0 in Q4 2025.

  • Quarterly Capital Expenditures fell 77.67% year-over-year to $272000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.8 million (down 22.79% YoY) and the FY2025 annual result came in at $3.8 million, down 22.79% from the prior year.
  • Capital Expenditures declined to $272000.0 in Q4 2025, from $610000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $44.9 million in Q4 2022 to a low of -$26.3 million in Q3 2022.
  • A 5-year average of $5.1 million and a median of $2.7 million in 2023 frame the typical range for Capital Expenditures.
  • Annual changes were most pronounced in 2022 — Capital Expenditures sank 321.33% — and 2025, when it soared 370.57%.
  • Tracing MGTX's Capital Expenditures over 5 years: stood at $24.4 million in 2021, then jumped by 84.05% to $44.9 million in 2022, then tumbled by 96.0% to $1.8 million in 2023, then slumped by 32.11% to $1.2 million in 2024, then plunged by 77.67% to $272000.0 in 2025.
  • The last three Capital Expenditures figures came in at $272000.0 (Q4 2025), $610000.0 (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 272,000.00
Sep 30, 2025 610,000.00
Jun 30, 2025 1.23 Mn
Mar 31, 2025 1.71 Mn
Dec 31, 2024 1.22 Mn
Sep 30, 2024 730,000.00
Jun 30, 2024 1.33 Mn
Mar 31, 2024 1.68 Mn
Dec 31, 2023 3.03 Mn
Sep 30, 2023 3.56 Mn
Jun 30, 2023 4.98 Mn
Mar 31, 2023 8.61 Mn
Dec 31, 2022 8.49 Mn
Sep 30, 2022 10.01 Mn
Jun 30, 2022 14.00 Mn
Mar 31, 2022 12.46 Mn
Dec 31, 2021 24.37 Mn
Sep 30, 2021 11.91 Mn
Jun 30, 2021 5.58 Mn
Mar 31, 2021 4.50 Mn